Texas Pacific Group, the buyout house, is buying a blood transfusion business for $540m (€425m) alongside a hedge fund, just a day after joining Apollo in a $15bn bid for US casino operator Harrah's.

Under the terms of the agreement, Texas Pacific Group and hedge fund Maverick Capital will acquire Transfusion Therapies, a unit of Baxter International that collects and processes blood.